Search results for Fda Approvals

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Datroway]]>

<![CDATA[FDA Approves Foundayo Under National Priority Voucher Program]]>

<![CDATA[Travere Therapeutics’ Filspari Receives Full FDA Approval ]]>

FDA Approvals in Oncology: January-March 2026

In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic cancer, and more. The post FDA Approvals in Oncology: Ja...

<![CDATA[Pharmaceutical Executive Daily: Idvynso Receives FDA Approval]]>

<![CDATA[FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection ]]>

<![CDATA[FDA Approves Bizengri for Adults with NRG1 Fusion-Positive Cholangiocarcinoma]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Beqalzi and Inqovi]]>

<![CDATA[FDA Approves Caplyta for Prevention of Schizophrenia in Adults ]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Hepcludex]]>

<![CDATA[FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhi...

<![CDATA[FDA Approves Fasenra for Hypereosinophilic Syndrome]]>

<![CDATA[FDA’s Oncologic Drugs Advisory Committee Recognizes Favorable Risk Benefit for Truqap ]]>

<![CDATA[FDA Expands Enhertu in Early HER2-Positive Breast Cancer]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Auvelity]]>

<![CDATA[FDA Approves Idvynso for Treatment of HIV-1 Infection in Adults]]>

<![CDATA[FDA Issues CRL to AbbVie for TrenibotulinumtoxinE’s Biologics License Application ]]>

FDA Approves First Generic Farxiga (dapagliflozin) Tablets

April 7, 2026 -- The U.S. Food and Drug Administration approved the first generics of Farxiga (dapagliflozin) tablets to reduce the risk of hospitalization for heart failure in adu...

FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review

WEDNESDAY, April 29, 2026 — The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon...

<![CDATA[FDA Approves Hepcludex as First and Only Approved Treatment for Chronic Hepatitis Delta Virus]]>

May 11 2026 - FDA mulls repurposing approved drugs to expand access

May 11 2026 - FDA mulls repurposing approved drugs to expand access admin Mon, 05/11/2026 - 11:47 From FDA policy signals to big strategic goals, today’s headlines...

<![CDATA[FDA Approves Otarmeni Gene Therapy for OTOF-Related Hearing Loss]]>

<![CDATA[ICER and Verdant Research Publish White Paper Examining FDA’s Accelerated Approval Pathway]]>